Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(13)
Published: Jan. 20, 2024
Stem
cell-derived
pancreatic
progenitors
(SC-PPs),
as
an
unlimited
source
of
SC-derived
β
(SC-β)
cells,
offers
a
robust
tool
for
diabetes
treatment
in
stem
cell-based
transplantation,
disease
modeling,
and
drug
screening.
Whereas,
PDX1
Cell stem cell,
Journal Year:
2023,
Volume and Issue:
30(5), P. 530 - 548
Published: May 1, 2023
The
generation
of
islet-like
endocrine
clusters
from
human
pluripotent
stem
cells
(hPSCs)
has
the
potential
to
provide
an
unlimited
source
insulin-producing
β
for
treatment
diabetes.
In
order
this
cell
therapy
become
widely
adopted,
highly
functional
and
well-characterized
cell-derived
islets
(SC-islets)
need
be
manufactured
at
scale.
Furthermore,
successful
SC-islet
replacement
strategies
should
prevent
significant
loss
immediately
following
transplantation
avoid
long-term
immune
rejection.
This
review
highlights
most
recent
advances
in
characterization
SC-islets
as
well
ensure
graft
viability
safety
after
transplantation.
Nature Biotechnology,
Journal Year:
2023,
Volume and Issue:
42(3), P. 413 - 423
Published: May 8, 2023
Abstract
Genetic
engineering
of
allogeneic
cell
therapeutics
that
fully
prevents
rejection
by
a
recipient’s
immune
system
would
abolish
the
requirement
for
immunosuppressive
drugs
or
encapsulation
and
support
large-scale
manufacturing
off-the-shelf
products.
Previously,
we
generated
mouse
human
hypoimmune
pluripotent
(HIP)
stem
cells
depleting
HLA
class
I
II
molecules
overexpressing
CD47
(
B2M
−/−
CIITA
+
).
To
determine
whether
this
strategy
is
successful
in
non-human
primates,
engineered
rhesus
macaque
HIP
transplanted
them
intramuscularly
into
four
macaques.
The
survived
unrestricted
16
weeks
immunocompetent
recipients
differentiated
several
lineages,
whereas
wild-type
were
vigorously
rejected.
We
also
endocrinologically
active
pancreatic
islet
showed
they
immunocompetent,
diabetic
humanized
mice
4
ameliorated
diabetes.
HIP-edited
primary
islets
40
an
recipient
without
immunosuppression,
unedited
quickly
Science Translational Medicine,
Journal Year:
2023,
Volume and Issue:
15(691)
Published: April 12, 2023
Transplantation
of
allogeneic
pancreatic
donor
islets
has
successfully
been
performed
in
selected
patients
with
difficult-to-control
insulin-dependent
diabetes
and
impaired
awareness
hypoglycemia
(IAH).
However,
the
required
systemic
immunosuppression
associated
this
procedure
prevents
cell
replacement
therapy
from
more
widespread
adoption
larger
patient
populations.
We
report
editing
primary
human
islet
cells
to
hypoimmune
HLA
class
I-
II-negative
CD47-overexpressing
phenotype
their
reaggregation
into
HIP
pseudoislets
(p-islets).
Human
p-islets
were
shown
survive,
engraft,
ameliorate
immunocompetent,
allogeneic,
diabetic
humanized
mice.
p-islet
further
avoid
autoimmune
killing
autologous,
The
survival
endocrine
function
not
by
contamination
unedited
or
partially
edited
within
p-islets.
eliminated
quickly
reliably
model
using
a
CD47-targeting
antibody,
thus
providing
safety
strategy
case
exert
toxicity
future
clinical
setting.
for
which
no
is
potential
lead
wider
help
IAH
history
severe
hypoglycemic
events
achieve
insulin
independence.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 7, 2025
Pancreatic
islets
are
densely
packed
cellular
aggregates
containing
various
hormonal
cell
types
essential
for
blood
glucose
regulation.
Interactions
among
these
cells
markedly
affect
the
glucoregulatory
functions
of
along
with
surrounding
niche
and
pancreatic
tissue-specific
geometrical
organization.
However,
stem
(SC)-derived
generated
in
vitro
often
lack
three-dimensional
extracellular
microenvironment
peri-vasculature,
which
leads
to
immaturity
SC-derived
islets,
reducing
their
ability
detect
fluctuations
insulin
release.
Here,
we
bioengineer
vivo-like
niches
by
optimizing
combination
matrix
basement
membrane
proteins
utilizing
bioprinting-based
guidance
recreate
spatial
pattern
islet
peripheries.
The
bioprinted
islet-specific
promotes
coordinated
interactions
between
vasculature,
supporting
structural
functional
features
resembling
native
islets.
Our
strategy
not
only
improves
functionality
but
also
offers
significant
potential
advancing
research
on
development,
maturation,
diabetic
disease
modeling,
future
implications
translational
applications.
Stem Cell Research & Therapy,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: July 15, 2022
Abstract
Type
1
diabetes
mellitus
(T1D)
is
a
chronic
disease
characterized
by
an
autoimmune
destruction
of
insulin-producing
β
-pancreatic
cells.
Although
many
advances
have
been
achieved
in
T1D
treatment,
current
therapy
strategies
are
often
unable
to
maintain
perfect
control
glycemic
levels.
Several
studies
searching
for
new
and
improved
methodologies
expansion
-cell
cultures
vitro
increase
the
supply
these
cells
pancreatic
islets
replacement
therapy.
A
promising
approach
consists
differentiation
stem
into
(IPCs)
sufficient
number
functional
status
be
transplanted.
Differentiation
protocols
designed
using
consecutive
cytokines
or
signaling
modulator
treatments,
at
specific
dosages,
activate
inhibit
main
pathways
that
induced
pluripotent
(iPSCs)
-cells.
Here,
we
provide
overview
approaches
achievements
obtaining
cell-derived
-cells
numerous
challenges,
which
still
need
overcome
achieve
this
goal.
Clinical
translation
cells-derived
efficient
maintenance
long-term
euglycemia
remains
major
issue.
Therefore,
research
efforts
directed
final
steps
differentiation,
aiming
production
mature
integration
interdisciplinary
fields
generate
cell
capable
reversing
clinical
outcome
T1D.
Nature Cell Biology,
Journal Year:
2023,
Volume and Issue:
25(6), P. 904 - 916
Published: May 15, 2023
Abstract
Insulin-producing
β
cells
created
from
human
pluripotent
stem
have
potential
as
a
therapy
for
insulin-dependent
diabetes,
but
cell-derived
islets
(SC-islets)
still
differ
their
in
vivo
counterparts.
To
better
understand
the
state
of
cell
types
within
SC-islets
and
identify
lineage
specification
deficiencies,
we
used
single-nucleus
multi-omic
sequencing
to
analyse
chromatin
accessibility
transcriptional
profiles
primary
islets.
Here
provide
an
analysis
that
enabled
derivation
gene
lists
activity
identifying
each
SC-islet
type
compared
with
Within
SC-islets,
found
difference
between
awry
enterochromaffin-like
is
gradient
states
rather
than
stark
identity.
Furthermore,
transplantation
improved
cellular
identities
overtime,
while
long-term
vitro
culture
did
not.
Collectively,
our
results
highlight
importance
landscapes
during
islet
maturation.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Sept. 2, 2023
Understanding
pancreas
development
can
provide
clues
for
better
treatments
of
pancreatic
diseases.
However,
the
molecular
heterogeneity
and
developmental
trajectory
early
human
are
poorly
explored.
Here,
we
performed
large-scale
single-cell
RNA
sequencing
assay
transposase
accessible
chromatin
embryonic
tissue
obtained
from
first-trimester
embryos.
We
unraveled
heterogeneity,
trajectories
regulatory
networks
major
cell
types.
The
results
reveal
that
dorsal
multipotent
cells
in
humans
exhibit
different
gene
expression
patterns
than
ventral
cells.
Pancreato-biliary
progenitors
generate
were
identified.
Notch
MAPK
signals
mesenchymal
regulate
differentiation
into
trunk
duct
Notably,
identified
endocrine
progenitor
subclusters
with
potentials.
Although
largely
conserved
between
mice,
some
distinct
have
also
been
Overall,
a
comprehensive
landscape
to
understand
its
lineage
transitions
complexity.